.Nature Medication, Released online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin led to boosted progression-free and total survival, resulting in FDA approval and a new procedure possibility for clients.